New approaches to risk assessment of chemical mixtures Peer-Reviewed Publications peerreviewedpublications Systems Toxicologysystemstoxicology Jan 3, 2019 20190103 Toxicology Research and Application /content/dam/pmiscience/default-fallback-thumbnails/publication/pmi-science-statistics-default-thumbnail.png Toxicology Research and Application
      Peer-Reviewed Publications

      New approaches to risk assessment of chemical mixtures

      Hayes, A. W.; Li, R.; Hoeng, J.; Iskandar, A.; Peitsch, M. C.; Dourson, M. L.
      Published
      Jan 3, 2019
      DOI
      10.1177/2397847318820768
      Link to publication
      Topic
      Summary

      Assessing the risk of chemical mixtures is an intricate process that should integrate published laboratory data; comparisons with the composition, toxicity, and functionality of similar mixtures; complete analytical characterization of the mixture components; and in silico modeling. Various tiered assessment protocols have been proposed to address this need, and these protocols may be adapted on a case-by-case basis for both mixture-based and component-based evaluations. Emerging technologies have enabled rapid mixture testing in alternative animal models, such as human organotypic cultures and zebrafish. In addition, quantitative modeling that uses systems toxicology approaches can identify exposure-induced cellular and molecular alterations that would not be detected by standard toxicology assays. This review summarizes the approaches to risk assessment of complex chemical mixtures as presented at the Eighth International Congress of the Asian Society of Toxicology, June 2018.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.